IRIS
BERTONI, Simona
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.679
AS - Asia 6.771
EU - Europa 5.867
SA - Sud America 826
AF - Africa 386
Continente sconosciuto - Info sul continente non disponibili 17
OC - Oceania 6
Totale 24.552
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.395
SG - Singapore 2.350
CN - Cina 2.004
IT - Italia 1.063
VN - Vietnam 1.043
FI - Finlandia 975
IE - Irlanda 804
SE - Svezia 783
BR - Brasile 658
DE - Germania 596
UA - Ucraina 464
HK - Hong Kong 450
FR - Francia 245
ZA - Sudafrica 243
NL - Olanda 239
GB - Regno Unito 237
BD - Bangladesh 215
TR - Turchia 193
CA - Canada 181
IN - India 139
RU - Federazione Russa 113
BE - Belgio 73
AR - Argentina 65
CI - Costa d'Avorio 65
ES - Italia 57
MX - Messico 50
AT - Austria 49
JP - Giappone 43
CZ - Repubblica Ceca 42
TH - Thailandia 39
IQ - Iraq 35
PH - Filippine 35
KR - Corea 33
PK - Pakistan 33
PL - Polonia 31
ID - Indonesia 28
EC - Ecuador 24
CO - Colombia 21
RO - Romania 20
EU - Europa 17
MA - Marocco 17
TW - Taiwan 16
VE - Venezuela 16
LT - Lituania 15
EG - Egitto 14
MY - Malesia 13
PY - Paraguay 12
JM - Giamaica 11
UZ - Uzbekistan 11
ET - Etiopia 10
KE - Kenya 10
PA - Panama 10
SA - Arabia Saudita 10
AE - Emirati Arabi Uniti 9
BO - Bolivia 9
CL - Cile 9
HU - Ungheria 9
IR - Iran 9
AZ - Azerbaigian 8
CR - Costa Rica 8
NP - Nepal 8
TN - Tunisia 8
JO - Giordania 7
LB - Libano 7
DO - Repubblica Dominicana 6
UY - Uruguay 6
BY - Bielorussia 5
DZ - Algeria 5
HR - Croazia 5
KZ - Kazakistan 5
PE - Perù 5
AL - Albania 4
AU - Australia 4
BG - Bulgaria 4
DK - Danimarca 4
HN - Honduras 4
IL - Israele 4
MD - Moldavia 4
OM - Oman 4
PT - Portogallo 4
QA - Qatar 4
SI - Slovenia 4
SN - Senegal 4
TT - Trinidad e Tobago 4
CH - Svizzera 3
EE - Estonia 3
PS - Palestinian Territory 3
RS - Serbia 3
SC - Seychelles 3
SK - Slovacchia (Repubblica Slovacca) 3
SY - Repubblica araba siriana 3
AO - Angola 2
BN - Brunei Darussalam 2
CM - Camerun 2
LY - Libia 2
NI - Nicaragua 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
SV - El Salvador 2
Totale 24.534
Salva come PNG Salva come JPEG
Città #
Dallas 2.937
Singapore 1.275
Ashburn 950
Dublin 803
Chandler 790
San Jose 712
Santa Clara 515
Jacksonville 494
Beijing 472
Hong Kong 417
Ann Arbor 383
Dearborn 376
Ho Chi Minh City 322
Parma 312
Boardman 292
Johannesburg 231
New York 224
Hanoi 212
Nanjing 187
Munich 176
Los Angeles 165
Shanghai 156
Izmir 154
Princeton 138
Lauterbourg 137
Wilmington 107
Hefei 91
San Mateo 90
Toronto 86
Helsinki 84
Buffalo 70
São Paulo 68
Abidjan 65
Brussels 65
Hebei 64
Nanchang 62
Kunming 60
Bremen 55
Guangzhou 55
Jinan 54
Moscow 54
Shenyang 50
Frankfurt am Main 49
Chicago 48
Haiphong 48
Woodbridge 44
Changsha 43
Bologna 40
London 40
Seattle 40
Da Nang 39
Montreal 38
Vienna 38
Des Moines 37
Council Bluffs 36
Milan 35
Tokyo 34
Groningen 33
Tianjin 33
Columbus 30
Turku 30
Bangalore 27
Brooklyn 27
Grafing 27
Marseille 27
Amsterdam 26
Auburn Hills 24
Fremont 24
Norwalk 24
Orem 24
Brno 23
Houston 23
Reggio Emilia 23
Rio de Janeiro 23
Rome 23
Warsaw 23
Hangzhou 21
Jiaxing 21
Atlanta 20
Zhengzhou 20
Denver 18
Manchester 18
Modena 18
Hải Dương 17
Nuremberg 17
Stockholm 17
Bangkok 16
Chennai 16
Curitiba 16
Mexico City 16
Belo Horizonte 15
Boston 15
Brescia 15
Jakarta 15
Madrid 15
Ottawa 15
Pune 15
Dhaka 14
Naples 14
Redondo Beach 14
Totale 15.511
Salva come PNG Salva come JPEG
Nome #
1,8-Naphthyridines IX. Potent anti-inflammatory and/or analgesic activity of a new group of substituted 5 amino[1,2,4]triazolo[4,3-a] [1,8]naphthyridine-6 carboxamides, of some their Mannich base derivatives and of one novel substituted 5-amino-10-oxo-10Hpyrimido[1,2-a [1,8]naphthyridine-6-carboxamide derivative 1.699
1,4-dioxane, a suitable scaffold for the development of novel M3 muscarinic receptor antagonists 1.632
Targeting the Eph/ephrin system as anti-inflammatory strategy in IBD 253
Pharmacological characterization of second generation FXR agonists as effective EphA2 antagonists: A successful application of target hopping approach 251
Inhibition of Eph/ephrin interaction with the small molecule UniPR500 improves glucose tolerance in healthy and insulin-resistant mice 243
Development of inhalation powders containing lactic acid bacteria with antimicrobial activity against Pseudomonas aeruginosa 229
An Enhanced Dissolving Cyclosporin-A Inhalable Powder Efficiently Reduces SARS-CoV-2 Infection In Vitro 228
Antiplatelet and antithrombotic activities of essential oil from wild Ocotea quixos (Lam.) Kosterm. (Lauraceae) calices from Amazonian Ecuador 219
Development of an orally bioavailable small molecule targeting Eph-ephrin system: in vitro and in vivo anticancer activity. 217
A promising imidazole-free histamine H3 receptor antagonist with good brain penetration and anticholinesterase activity. 213
Dibasic biphenyl H(3) receptor antagonists: Steric tolerance for a lipophilic side chain. 208
Bifidobacterium bifidum PRL2010 alleviates intestinal ischemia/reperfusioni injury 208
Bithiazole Inhibitors of Phosphatidylinositol 4-Kinase (PI4KIIIβ) as Broad-Spectrum Antivirals Blocking the Replication of SARS-CoV-2, Zika Virus, and Human Rhinoviruses 199
Synthesis, biological activity, QSAR and QSPR study of 2/aminobenzimidazole derivatives as potent H3-antagonists 198
Protective Effects of a Protease Inhibitor (Gabexate Mesilate) on Intestinal Ischemia/Reperfusion Injury in Rats 194
1,8-Naphthyridines VII. New substituted 5-amino[1,2,4]triazolo[4,3-a][1,8]naphthyridine-6-carboxamides and their isosteric analogues, exhibiting notable anti-inflammatory and/or analgesic activities, but no acute gastrolesivity. 193
1,8-Naphthyridines VIII. Novel 5-aminoimidazo[1,2-a] [1,8]naphthyridine-6-carboxamide and 5-amino[1,2,4]triazolo[4,3-a] [1,8]naphthyridine-6-carboxamide derivatives showing potent analgesic or anti-inflammatory activity, respectively, and completely devoid of acute gastrolesivity. 192
Accommodation and peristalsis are functional responses to chronic obstruction in rat hypertrophic ileum 190
Impact of S1P mimetics on mesenteric ischemia/reperfusion injury 186
Human colonoid-derived monolayers and Caco-2: comparative analysis of inflammatory responses 185
Multi-Target CFTR Modulators Endowed with Multiple Beneficial Side Effects for Cystic Fibrosis Patients: Toward a Simplified Therapeutic Approach 185
The Role of HB-Donor Groups in the Heterocyclic Polar Fragment of H3-Antagonists. I. Synthesis and Biological Assays 183
Caratterizzazione farmacologica in vitro di nuovi agonisti muscarinici analoghi dell'Oxotremorina 179
Cognition enhancing effect in rats of a selected histamine H3 receptor antagonist with good brain penetration 178
NEW EPH ANTAGONISTS DISCRIMINATING BETWEEN EPH-AS AND EPH-BS CLASSES 177
Validation of a histamine H3 receptor model through structure–activity relationships for classical H3 antagonists 177
Access to CNS of selected H3-antagonists: ex vivo binding study in rats 177
Suppression of inflammatory events associated to intestinal ischemia-reperfusion by 5-HT1A blockade in mice 176
Gastrointestinal symptoms and local oxidative stress in a model of Parkinson's Disease in rats 176
Daily assumption of fermented milk containing Bifidobacterium breve 246 B® promotes prophylactic effects against intestinal inflammation in mice 175
Adaptive changes in rat ileum motility induced by mild mesenteric ischemia/reperfusion injury: role of endogenous mediators and reperfusion time 170
Accommodation and peristalsis are functional responses to obstruction in rat hypertrophic ileum 168
Elucidating the gut microbiome of ulcerative colitis: bifidobacteria as novel microbial biomarkers 168
Histamine H4 receptor antagonism and mesenteric ischemia/reperfusion injury in mice 167
Novel Analgesic Agents Obtained by Molecular Hybridization of Orthosteric and Allosteric Ligands 167
Analgesici-antipiretici benzopirano pirimidinici non acidici attivi per via orale privi di gastrolesività 167
Probing the effects of MR120 in preclinical chronic colitis: A first-in-class anti-IBD agent targeting the CCL20/CCR6 axis 166
UniPR1331: small Eph/ephrin antagonist beneficial in intestinal inflammation by interfering with type-B signaling 165
Dual-Acting Drugs: an in vitro Study of Nonimidazole Histamine H(3) Receptor Antagonists Combining Anticholinesterase Activity 164
Dibasic non-imidazole histamine H3 receptor antagonists with a rigid byphenyl scaffold. 162
5-HT1A receptors as target to protect the intestine in an experimental model of colitis 162
Intestinal chronic obstruction affects motor responsiveness of rat hypertrophic longitudinal and circular muscles 162
Discovery of small-molecule targeting the CCL20/CCR6 axis as first-in-class inhibitors for inflammatory bowel diseases 161
Dual role of endogenous serotonin in 2,4,6-Trinitrobenzene Sulfonic Acid-induced colitis 161
Multiple approaches for the discovery and development of small molecules targeting Eph-ephrin protein-protein interaction 161
Biochemical platform for the identification of adverse effects triggered by free hemoglobin in guinea pigs 160
Analgesic activity of new hybrid muscarinic agonists in mice 160
Eph/ephrin targeting with a small molecule improves glucose tolerance in healthy and insulin-resistant mice 159
QSAR study of 2-aminobenzimidazole derivatives as H3 antagonists 159
Botanicals used as food supplements interfering with EphA2-ephrinA1 system: a screening study 158
Effect of μ Opioid Receptor Activation On Intestinal Ischemia/Reperfusion Injury in Mice 157
Access to CNS of selected H3-antagonists: ex vivo binding study in rats 156
Motor responses of rat hypertrophic intestine following chronic obstruction 155
Radiological analysis of gastrointestinal dysmotility in a model of central nervous dopaminergic degeneration: Comparative study with conventional in vivo techniques in the rat 155
Intestinal Hypoxia and reperfusion: role for Eph-ephrin system 155
Nuovi potenti agonisti muscarinici oxotremorina-M simili a struttura acetilenica: studio funzionale in vitro 152
Role of 5-HT in intestinal ischemia-reperfusion: suppression of inflammatory events by 5-HT1A blockade in mice 150
Influence of Nitric Oxide system in mesenteric ischemia-reperfusion induced injury in mice 150
Influence of adenosine in the systemic and local injury caused by mesenteric ischemia-reperfusion in mice 150
Alterations of intestinal motor responsiveness in a model of mild mesenteric ischemia/reperfusion in rats 150
Δ5-Cholenoyl-amino acids as selective and orally available antagonists of the Eph-ephrin system 150
PHARMACOLOGICAL CHARACTERIZATION OF NEW COMPOUNDS AIMED AT INHIBITING EPH-EPHRIN INTERACTION IN GLIOBLASTOMA 148
Benzofuran-2-Carboxamide Derivatives as Immunomodulatory Agents Blocking the CCL20-Induced Chemotaxis and Colon Cancer Growth 147
Assessment of intestinal motor responsiveness in an ischemia/reperfusion model in rats 147
Preventive effect of 5-HT1A receptor agonist Buspirone on mesenteric ischemia/reperfusion-induced inflammatory injuries in mice 147
Discovery and development of low molecular weight Eph-ephrin protein-protein inhbi-tors endowed with antiangiogenic activity 145
CNS access of selected H3-antagonists: ex vivo binding study in rats 144
Distinct Roles of α4β2 and α7 Nicotinic Receptors in the Modulation of Inflammatory Responses in TNBS-Induced Colitis 143
Heterogeneous response of colonoid-derived monolayers to TNFa and IFNg exposure: functional and morphological characterization 142
Influence of gender in the mesenteric ischemia/reperfusion model in mice 142
The selective inhibition of inducible nitric oxide synthase prevents intestinal ischemia-reperfusion injury in mice 141
In vitro and in vivo pharmacological analysis of imidazole-free histamine H3 receptor antagonists: promising results for a brain-penetrating H3 blocker with weak anticholinesterase activity. 141
Development of a GPCR model for SAR interpretation of classical and new H3 antagonists 141
Preliminary study of calcium balance and bone mineralization improvement by a new calcium supplement in growing rats 141
Bis(ammonio)alkane-type agonists of muscarinic acetylcholine receptors: synthesis, in vitro functional characterization, and in vivo evaluation of their analgesic activity 140
Different role of the Histamine H3 Receptor in Vagal-, Betanechol-, Pentagastrin-induced Gastric Acid Secretion in Anaesthetized Rats 139
Activation of μ opioid receptors ameliorates mucosal injury induced by intestinal ischemia and reperfusion in mice 139
Up-regulation of inhibitory transmitters in myenteric neurons of the rat ileum in an acute model of ischemia/reperfusion 139
Synthesis and biological evaluation of new non-imidazole H(3)-receptor antagonists of the 2-aminobenzimidazole series 138
Discovery of histamine H3 receptor antagonistic property of simple imidazole-free derivatives: preliminary pharmacological investigation. 137
Indole-based analogs of melatonin: in vitro antioxidant and cytoprotective activities 136
Radiological analysis of gastrointestinal dysmotility associated with central dopaminergic impairment in an animal model of parkinson's disease (PD) 135
RESPONSIVENESS OF LONGITUDINAL AND CIRCULAR MUSCLE TO RELAXING MEDIATORS IS DIFFERENTIALLY AFFECTED IN RAT HYPERTROPHIED ILEUM 133
Disruption of Eph-ephrin B signaling pathways mitigates inflammation in a murine model of Crohn’s disease 133
Role of Glutamate- N-methyl-D-Aspartate (NMDA) Receptors in Neuronal Plasticity and Gastrointestinal Transit Delay Induced by Ischemia/Reperfusion in Rats 132
Protection by the EPH-EPHRIN System Against Mesenteric Ischemia-Reperfusion Injury 132
Evidence for the involvement of 5-HT(2A) receptors in mild mesenteric ischemia/reperfusion dysfunctions in mice 131
Synthesis and pharmacological screening of novel non-acidic gastric-sparing antiinflammatory/antiplatelet agents:5-alkyl/cycloalkylamino substituted 2-amino-5H-[1]benzopyrano[4,3-d]pyrimidines 131
Synthesis and structure-activity relationships for biphenyl H3 receptor antagonists with moderate anti-cholinesterase activity. 129
Mesenteric ischemia-reperfusion: an overview of preclinical drug strategies 128
Synthesis and Biological Evaluation of N-Pyrazolyl-N'-alkyl/benzyl/phenylureas: a New Class of Potent Inhibitors of Interleukin 8-Induced Neutrophil Chemotaxis 126
Screening di nuovi agenti antiinfiammatori/antiaggreganti non-acidici: sviluppo di 2-amino-5H-[1]benzopirano[4,3-d]pirimidine 5-alchil/cicloalchilamino sostituite prive di attivita' gastrolesiva 126
Synthesis and functional characterization of novel heterocyclic derivatives related to oxotremorine and oxotremorine-M 125
Involvement of 5-HT2A receptors in motor and inflammatory disorders induced by mesenteric ischemia reperfusion in mice 124
PHENYLPROPANOID RICH ESSENTIAL OILS AS POTENTIAL ANTITHROMBOTICS ENDOWED WITH GASTROPROTECTIVE EFFECTS 123
Interactions of new and conventional H3-blockers with non-histaminergic receptors involved in neurogenic and myogenic contractile responses of guinea-pig ileum 123
Allosteric Modulation of Muscarinic Acetylcholine-Receptors: Oxotremorine-Phthalimidoalkyl-Hybrids of the Hexamethonio-type 122
Glutamate receptor activation mediates the effects of ischemia/reperfusion on gastrointestinal transit and neuronal phenotypes in the rat myenteric plexus 122
Aminopyridine derivatives with anticholinesterase and antiamnesic activity 122
Pharmacological modulation of 5HT1A receptors in mice mesenteric ischemia/reperfusion injury: protective effect of Buspirone and WAY100135 121
Totale 19.122
Salva come PNG Salva come JPEG
Categoria #
all - tutte 74.998
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 74.998
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202124 0 0 0 0 0 0 0 0 0 0 0 24
2021/2022836 32 23 32 91 51 56 94 104 33 58 58 204
2022/20233.138 347 320 181 234 320 344 67 174 932 45 121 53
2023/20241.227 69 80 46 47 88 313 126 84 38 66 97 173
2024/20253.732 137 193 260 237 383 430 157 168 398 367 271 731
2025/202610.769 842 1.238 2.826 796 1.127 476 871 282 1.144 650 333 184
Totale 24.722